All News

Stephen Y. Nakada, MD, interviews Jihad Kaouk, MD, about the nuances of single-port surgery technique, patient selection, the learning curve, technical modifications, and outcomes.

Novartis has announced that RAD001 (everolimus), an oral once-daily inhibitor of mTOR, for treatment of advanced kidney cancer, has been granted priority review by the FDA.

An 11-year follow-up on the safety and efficacy of tension-free vaginal tape for female stress urinary incontinence found 90% of patients were objectively cured, and 97% considered themselves subjectively cured or improved.

Mitchell H. Sokoloff, MD, has been appointed chief of the section of urology and professor of surgery at the University of Arizona department of surgery. In this capacity, his objective will be to expand clinical, educational, and research programs in laparoscopy, voiding dysfunction, and urologic cancers, and to build a pediatric urology program in collaboration with university and community physicians.

Dendreon Corp. has initiated its second of two new phase II trials of sipuleucel-T (Provenge), the company’s investigational active cellular immunotherapy for the treatment of advanced prostate cancer.

Although cigarette smoking accounts for up to half of all bladder cancer cases, few people are aware of the connection, including more than three-quarters of patients who have the disease, according to a new study from the University of Michigan Comprehensive Cancer Center, Ann Arbor. This knowledge vacuum suggests that urologists need to communicate the risks of smoking to their patients and encourage them to quit, study authors say.

Brachytherapy may be a more beneficial treatment than surgery or external beam radiation therapy for overweight or obese prostate cancer patients, according to a study published in the International Journal of Radiation Oncology*Biology*Physics (2008; 71:1302-8).

One-fifth of men under age 50 reported undergoing a PSA test to detect prostate cancer in the previous year, yet only one in three young African-American men reported ever having had a PSA test in the previous year, according to researchers at the Duke University Prostate Center (Durham, NC). The findings appear in the June 23 online edition of Cancer and will appear in the Sept. 15 print edition.